Abstract

Human calcium-sensing receptor (CaSR) is a G-protein coupled receptor (GPCR) that maintains extracellular Ca2+ homeostasis through the regulation of parathyroid hormone secretion. It functions as a disulfide-tethered homodimer composed of three main domains, the Venus Flytrap module, cysteine-rich domain, and seven-helix transmembrane region. Here we present the crystal structures of the entire extracellular domain of CaSR in the resting and active conformations. We provide direct evidence that L-amino acids are agonists of the receptor. In the active structure, L-Trp occupies the orthosteric agonist-binding site at the interdomain cleft, and is primarily responsible for inducing extracellular domain closure to initiate receptor activation. Our structures reveal multiple binding sites for Ca2+ and PO43- ions. Both ions are crucial for structural integrity of the receptor. While Ca2+ ions stabilize the active state, PO43- ions reinforce the inactive conformation. The activation mechanism of CaSR involves the formation of a novel dimer interface between subunits.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Yong Geng

    Department of Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Lidia Mosyak

    Department of Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Igor Kurinov

    Department of Chemistry and Chemical Biology, Cornell University, Ithaca, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Hao Zuo

    Department of Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Emmanuel Sturchler

    Department of Molecular Therapeutics, The Scripps Translational Science Institute, Jupiter, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Tat Cheung Cheng

    Department of Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Prakash Subramanyam

    Department of Physiology and Cellular Biophysics, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Alice P Brown

    School of Life and Environmental Sciences, University of Sydney, New South Wales, Australia
    Competing interests
    The authors declare that no competing interests exist.
  9. Sarah C Brennan

    School of Life and Environmental Sciences, University of Sydney, New South Wales, Australia
    Competing interests
    The authors declare that no competing interests exist.
  10. Hee-chang Mun

    School of Life and Environmental Sciences, University of Sydney, New South Wales, Australia
    Competing interests
    The authors declare that no competing interests exist.
  11. Martin Bush

    Department of Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Yan Chen

    Department of Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Trang X Nguyen

    Department of Psychiatry, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Baohua Cao

    Department of Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Donald D Chang

    Department of Physiology and Cellular Biophysics, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Matthias Quick

    Department of Psychiatry, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Arthur D Conigrave

    School of Life and Environmental Sciences, University of Sydney, New South Wales, Australia
    Competing interests
    The authors declare that no competing interests exist.
  18. Henry M Colecraft

    Department of Physiology and Cellular Biophysics, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  19. Patricia McDonald

    Department of Molecular Therapeutics, The Scripps Translational Science Institute, Jupiter, United States
    Competing interests
    The authors declare that no competing interests exist.
  20. Qing R Fan

    Department of Pharmacology, Columbia University, New York, United States
    For correspondence
    qf13@cumc.columbia.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9330-0963

Funding

National Institute of General Medical Sciences (R01GM112973)

  • Qing R Fan

American Heart Association (15GRNT25420002)

  • Qing R Fan

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2016, Geng et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,713
    views
  • 1,632
    downloads
  • 196
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yong Geng
  2. Lidia Mosyak
  3. Igor Kurinov
  4. Hao Zuo
  5. Emmanuel Sturchler
  6. Tat Cheung Cheng
  7. Prakash Subramanyam
  8. Alice P Brown
  9. Sarah C Brennan
  10. Hee-chang Mun
  11. Martin Bush
  12. Yan Chen
  13. Trang X Nguyen
  14. Baohua Cao
  15. Donald D Chang
  16. Matthias Quick
  17. Arthur D Conigrave
  18. Henry M Colecraft
  19. Patricia McDonald
  20. Qing R Fan
(2016)
Structural mechanism of ligand activation in human calcium-sensing receptor
eLife 5:e13662.
https://doi.org/10.7554/eLife.13662

Share this article

https://doi.org/10.7554/eLife.13662

Further reading

    1. Structural Biology and Molecular Biophysics
    Parveen Goyal, KanagaVijayan Dhanabalan ... Subramanian Ramaswamy
    Research Advance

    N -Acetylneuraminic acid (Neu5Ac) is a negatively charged nine-carbon amino sugar that is often the peripheral sugar in human cell-surface glycoconjugates. Some bacteria scavenge, import, and metabolize Neu5Ac or redeploy it on their cell surfaces for immune evasion. The import of Neu5Ac by many bacteria is mediated by tripartite ATP-independent periplasmic (TRAP) transporters. We have previously reported the structures of SiaQM, a membrane-embedded component of the Haemophilus influenzae TRAP transport system, (Currie et al., 2024). However, none of the published structures contain Neu5Ac bound to SiaQM. This information is critical for defining the transport mechanism and for further structure-activity relationship studies. Here, we report the structures of Fusobacterium nucleatum SiaQM with and without Neu5Ac. Both structures are in an inward (cytoplasmic side) facing conformation. The Neu5Ac-bound structure reveals the interactions of Neu5Ac with the transporter and its relationship with the Na+ binding sites. Two of the Na+-binding sites are similar to those described previously. We identify a third metal-binding site that is further away and buried in the elevator domain. Ser300 and Ser345 interact with the C1-carboxylate group of Neu5Ac. Proteoliposome-based transport assays showed that Ser300-Neu5Ac interaction is critical for transport, whereas Ser345 is dispensable. Neu5Ac primarily interacts with residues in the elevator domain of the protein, thereby supporting the elevator with an operator mechanism. The residues interacting with Neu5Ac are conserved, providing fundamental information required to design inhibitors against this class of proteins.

    1. Computational and Systems Biology
    2. Structural Biology and Molecular Biophysics
    Bin Zheng, Meimei Duan ... Peng Zheng
    Research Article

    Viral adhesion to host cells is a critical step in infection for many viruses, including monkeypox virus (MPXV). In MPXV, the H3 protein mediates viral adhesion through its interaction with heparan sulfate (HS), yet the structural details of this interaction have remained elusive. Using AI-based structural prediction tools and molecular dynamics (MD) simulations, we identified a novel, positively charged α-helical domain in H3 that is essential for HS binding. This conserved domain, found across orthopoxviruses, was experimentally validated and shown to be critical for viral adhesion, making it an ideal target for antiviral drug development. Targeting this domain, we designed a protein inhibitor, which disrupted the H3-HS interaction, inhibited viral infection in vitro and viral replication in vivo, offering a promising antiviral candidate. Our findings reveal a novel therapeutic target of MPXV, demonstrating the potential of combination of AI-driven methods and MD simulations to accelerate antiviral drug discovery.